Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Mylan revenue increased from $11.4 billion in 2018 to $11.5 billion in 2019, a (0.6%) increase.

Annual Revenue ($)

Mylan revenue was $11.5 b in FY, 2019 which is a (0.6%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019
Revenue$11.91 b$11.43 b$11.5 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$2.68 b$2.81 b$2.86 b$2.5 b$2.85 b$2.96 b$2.62 b$2.73 b$2.97 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Mylan revenue breakdown by business segment: 16.0% from Central Nervous System & Anesthesia, 14.5% from Infectious Disease, 15.9% from Respiratory & Allergy, 7.8% from Cardiovascular, 10.0% from Gastroenterology, 7.3% from Diabetes & Metabolism, 6.3% from Women’s Health, 9.2% from Oncology and 13.0% from Other

Mylan revenue breakdown by geographic segment: 27.9% from Rest of World, 36.6% from North America and 35.5% from Europe

FY, 2019FY, 2018FY, 2017
Central Nervous System & Anesthesia$1.82 b$1.94 b$1.72 b
Infectious Disease$1.65 b$1.53 b$1.32 b
Respiratory & Allergy$1.8 b$1.25 b$1.5 b
Cardiovascular$887.5 m$1.08 b$1.08 b
Gastroenterology$1.14 b$1.12 b$830.5 m
Diabetes & Metabolism$831.9 m$709.1 m$935.2 m
Dermatology$541 m$778.6 m$226.6 m
Women’s Health$714.7 m$708.3 m$467.7 m
Oncology$1.05 b$758.9 m$633.3 m
Immunology$150.6 m$106.8 m$118.1 m
Other$783.2 m$1.21 b$528.7 m
FY, 2019FY, 2018FY, 2017
Rest of World$3.17 b$3.02 b$3.24 b
North America$4.16 b$4.1 b$5.13 b
Europe$4.04 b$4.16 b$1.08 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu